Detalhe da pesquisa
1.
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Front Immunol
; 13: 1050250, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713447
2.
DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model.
Front Immunol
; 12: 785349, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35095861
3.
Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity.
Expert Opin Biol Ther
; 20(9): 1083-1097, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297534